Morgan Stanley analyst Bob Huang lowered the firm’s price target on Globe Life (GL) to $177 from $179 and keeps an Overweight rating on the shares. The firm updated models in the insurance space post the Q3 reports. Life insurance earnings reports were better than what share price reactions would suggest, the analyst tells investors in a research note. For property and casualty, Morgan Stanley sees a softening cycle heading into 2026.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GL:
- Globe Life Amends Executive Retirement Plan
- These 3 “Strong Buy” Value Stocks Have over 20% Upside, According to Analysts – 11/4/2025
- Globe Life announces three-year partnership with North Texas Food Bank
- Globe Life price target raised to $162 from $160 at Keefe Bruyette
- Globe Life Inc. Reports Strong Q3 Earnings Amid Challenges